High-risk adverse drug reactions: consideration of limited dialysis therapy for toxic epidermal necrolysis (TEN)

Guozhen Xie, Thais Pincelli, La Tonya J. Hickson, Rokea el-Azhary, Olayemi Sokumbi

Research output: Contribution to journalArticlepeer-review

Abstract

Toxic epidermal necrolysis (TEN) is a rare but often lethal drug reaction involving the skin. Treatment is often centered around suppurative care, and the mortality rate remains unacceptably high, although the clinical and epidemiological features of TEN have been well documented for decades. Recent studies have placed an emphasis on certain medications in the pathophysiology of severe TEN, and our colleagues previously reported several cases of clinical improvement in TEN patients following hemodialysis. Here, we discuss the major considerations for initiating dialysis in TEN patients. By doing so, we hope to encourage others to explore this potential avenue for treating TEN, one of the most serious medical emergencies in the field of dermatology.

Original languageEnglish (US)
Pages (from-to)5-9
Number of pages5
JournalInternational journal of dermatology
Volume63
Issue number1
DOIs
StatePublished - Jan 2024

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'High-risk adverse drug reactions: consideration of limited dialysis therapy for toxic epidermal necrolysis (TEN)'. Together they form a unique fingerprint.

Cite this